Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jose-Antonio Perez-Simon, MD-PhD
Hospitales Universitarios Virgen del Rocío
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ico- Hospital Germans Trias I Pujol
Badalona, Spain
- Hospital Clinic de Barcelona
Barcelona, Spain
- Hospital Universitario Vall D´hebrón
Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- Hospital Universitario Ramón Y Cajal
Madrid, Spain
- Hospital Clinico Universitario Salamanca
Salamanca, Spain
- Hospital Universitario Virgen del Rocío
Seville, Spain
- Hospital Clínico Universitario de Valencia
Valencia, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 May 2017
- Primary completion
- 11 Jan 2024
- Completion
- 31 Dec 2024
- Last update posted
- 30 Aug 2024
- Registered enrollment
- 142
- Registry id
- NCT03225417
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.